CAMS Meta-Analysis: Intervention for Suicidal Ideation

Dr. Joshua K. Swift

Published: May 17, 2021

A recent rigorous meta-analysis of the Collaborative Assessment and Management of Suicidality (“CAMS”) showed that it is a “Well Supported” intervention for reducing suicidal ideation per CDC criteria.

The meta-analysis was performed by Dr. Joshua K. Swift and his team at the Department of Psychology at Idaho State University. It included nine studies, primarily randomized controlled trials, with data from 749 patients where the CAMS intervention was compared to treatment as usual or, in one study, with Dialectical Behavior Therapy (“DBT for self harm”). The new study has just been published in the peer-reviewed journal, Suicide and Life-Threatening Behavior.

“The results showed that CAMS, in comparison to alternative interventions, resulted in significantly lower suicidal ideation and general distress, considerably higher treatment acceptability, and notably higher hope/lower hopelessness,” Dr. Swift explained.

To gain access to the article, enter your information.

Request access to the Meta-Analysis

Thank you

Click the button below to access the resource

About CAMS-care

CAMS Framework is first and foremost a clinical philosophy of care. It is a therapeutic framework for suicide-specific assessment and treatment of a patient’s suicidal risk. It is a flexible approach that can be used across theoretical orientations and disciplines for a wide range of suicidal patients across treatment settings and different treatment modalities. The clinician and patient engage in a highly interactive assessment process and the patient is actively involved in the development of their own treatment plan.